BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Foot and Ankle Devices Market – Forecast to 2028,’ thoroughly examines the Foot and Ankle Devices industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Ambulatory Surgery Center (ASC) Market – Forecast to 2028,’ thoroughly examines the Ambulatory Surgery Center (ASC) industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Preparative and Process Chromatography Market – Forecast to 2028,’ thoroughly examines the Preparative and Process Chromatography industry to provide essential data & information for the targeted readers.

Agilent Technologies Inc. (NYSE: A) today announced it will release financial results for the third quarter of fiscal year 2022 after the stock market closes on Tuesday, Aug. 16.

Cosán, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare company, have partnered to fill an existing gap in aging adult care management by providing Cosán’s network of physicians with Genomind’s integrated precision medication management platform.

Revolution Medicines, Inc., a clinical-stage oncology company developing targeted therapies for RAS-addicted cancers, announced the pricing of its underwritten public offering of 11,500,000 shares of common stock at a public offering price of $20.00 per share, before underwriting discounts and commissions.

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), and Ascentage Pharma (6855.HK), today announce that the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has accepted and granted Priority Review designation[1].